The effect of the pandemic period on Bladder Pain Syndrome patients under amitriptyline treatment

Basit Öğe Kaydı
dc.authoridozcan, ridvan/0000-0002-2083-3216
dc.authoridAKGUL, MURAT/0000-0001-6187-1940
dc.authoridYazici, Cenk Murat/0000-0001-6140-5181
dc.authoridSAHIN, MEHMET FATIH/0000-0002-0926-3005
dc.contributor.authorSahin, Mehmet Fatih
dc.contributor.authorOzcan, Ridvan
dc.contributor.authorMalak, Arzu
dc.contributor.authorDogan, Cagri
dc.contributor.authorYazici, Cenk Murat
dc.contributor.authorOzcan, Muege
dc.contributor.authorAkgul, Murat
dc.date.accessioned2024-10-29T17:58:17Z
dc.date.available2024-10-29T17:58:17Z
dc.date.issued2023
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstractIntroductionCOVID-19 is a disease that may cause anxiety, depression, and stress. Bladder pain syndrome (BPS) is a disease in which stress and psychological factors might negatively affect its course. In this study, we aimed to examine the possible clinical aggregation of the pandemic period on BPS patients. Materials and MethodsA total of 35 BPS patients diagnosed between 2010 and 2018 were included. All patients were using medical treatment, and the follow-up period was at least 6 months. According to our clinical follow-up protocol, the BPS patients were given the King's Health Questionnaire (KHQ), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), Overactive Bladder Form V8 (OAB-V8), and Visual Analog Score (VAS) in every visit. In the sixth month of the pandemic, the clinical course of the patients was questioned by telephone or video interview, and their treatment continuities were questioned. Information was received about the delays in their follow-up and the difficulties in accessing healthcare opportunities. The same questionnaires were filled out and compared with pre-pandemic scores. ResultsThe mean age of the patients included in the study was 50.2 +/- 13.32 (min:20, max:74), 11 were males and 24 were females. The mean follow-up periods were 71.8 +/- 35.6 months. All questionnaire scores showed an increase compared to the pre-pandemic period. A statistically significant increase was detected during the pandemic in all sub-units of the KHQ. The VAS and OAB-V8 scores of 16 patients who requested hospital admission were significantly higher than before the pandemic. However, there was no statistically significant difference in the increase in VAS and OAB-V8 scores of the 19 patients who refused to come to the hospital. ConclusionBPS patients have been negatively affected by the emotional effects of the COVID-19 pandemic. Due to the fear, stress, anxiety, and depression, the symptoms of BPS patients exacerbated, and the patients could not receive the necessary support due to a lack of regular follow-ups.
dc.identifier.doi10.1002/nau.25199
dc.identifier.endpage1193
dc.identifier.issn0733-2467
dc.identifier.issn1520-6777
dc.identifier.issue6en_US
dc.identifier.pmid37155258
dc.identifier.scopus2-s2.0-85158140466
dc.identifier.scopusqualityQ1
dc.identifier.startpage1188
dc.identifier.urihttps://doi.org/10.1002/nau.25199
dc.identifier.urihttps://hdl.handle.net/20.500.11776/14185
dc.identifier.volume42
dc.identifier.wosWOS:000983203800001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofNeurourology and Urodynamics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectanxiety
dc.subjectbladder pain syndrome
dc.subjectCOVID-19
dc.subjectdepression
dc.titleThe effect of the pandemic period on Bladder Pain Syndrome patients under amitriptyline treatment
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu